NP
Nandan Pejavar Rao
About Nandan Pejavar Rao
Data last updated:
Nandan Pejavar Rao is a Director at Remidex Pharma Private Limited (since 2018), Director at Ishaan Labs Private Limited (since 2018) and Director at Sanil Pharmaceuticals Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹24.75 Cr; the largest is Remidex Pharma Private Limited at ₹24.55 Cr (FY 2025). Earlier, Nandan Pejavar Rao was a Director at Alleviative Health Solutions Private Limited (from 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Oct 2018 | 1981 | ₹24.55 Cr (FY 2025) | Active | |
| Director | 24 Oct 2018 | 1995 | ₹10.5 Lakh (FY 2025) | Active | |
| Director | 24 Oct 2018 | 1989 | ₹9.5 Lakh (FY 2025) | Active | |
| Designated Partner | 27 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Aug 2023 | 2023 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nandan Pejavar Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ishaan Pejavar Rao | 08262033 | Remidex Pharma Private Limited , Ishaan Labs Private Limited and 2 more | Director |
| Nilima Dayanand Rao | 00737692 | Remidex Pharma Private Limited , Ishaan Labs Private Limited and 2 more | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nandan Pejavar Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nandan Pejavar Rao
Nandan Pejavar Rao currently holds 4 directorships: Remidex Pharma Private Limited (Director, since 24 Oct 2018, revenue ₹24.55 Cr (FY 2025)); Ishaan Labs Private Limited (Director, since 24 Oct 2018, revenue ₹10.5 Lakh (FY 2025)); Sanil Pharmaceuticals Private Limited (Director, since 24 Oct 2018, revenue ₹9.5 Lakh (FY 2025)); Surima Ventures Llp (Designated Partner, since 27 Jan 2025).
Nandan Pejavar Rao was first appointed on 24 Oct 2018 as Director at Remidex Pharma Private Limited. The most recent appointment on record is 27 Jan 2025 at Surima Ventures Llp.
The 3 current companies of Nandan Pejavar Rao that report revenue have a combined latest revenue of ₹24.75 Cr: Remidex Pharma Private Limited ₹24.55 Cr (FY 2025); Ishaan Labs Private Limited ₹10.5 Lakh (FY 2025); Sanil Pharmaceuticals Private Limited ₹9.5 Lakh (FY 2025).
Nandan Pejavar Rao held 1 earlier board appointment: Alleviative Health Solutions Private Limited (Director, from 08 Aug 2023).
The current boards of Nandan Pejavar Rao's companies include Ishaan Pejavar Rao (Remidex Pharma Private Limited), Nilima Dayanand Rao (Remidex Pharma Private Limited).